We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.36%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$16.2B
AUM Growth
+$1.63B
Cap. Flow
+$893M
Cap. Flow %
5.51%
Top 10 Hldgs %
15.16%
Holding
2,286
New
215
Increased
1,251
Reduced
646
Closed
120

Sector Composition

Rank Sector Weight
1 Energy 9.92%
2 Technology 7.94%
3 Healthcare 7.8%
4 Financials 7.55%
5 Industrials 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRE
2251
DELISTED
BRE PROPERTIES INC CL A
BRE
-41,413
Closed -$2.6M
IRE
2252
DELISTED
GOVERNOR-BK OF IRELND ADS NEW
IRE
-10,500
Closed -$203K
PEI
2253
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
-6,758
Closed -$1.83M
CEO
2254
DELISTED
CNOOC Limited
CEO
-10,646
Closed -$1.62M
SGY
2255
DELISTED
Stone Energy
SGY
-323
Closed -$771K
NTT
2256
DELISTED
Nippon Telegraph & Telephone
NTT
-53,111
Closed -$1.45M
QUNR
2257
DELISTED
Qunar Cayman Islands Limited
QUNR
-11,735
Closed -$359K
DO
2258
DELISTED
Diamond Offshore Drilling
DO
-218,524
Closed -$10.7M

Similar funds

Raymond James & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Raymond James & Associates held 2,286 positions worth $16.2B, up 11% from $14.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $893M of net new capital in Q2 2014, opening 215 new positions and adding to 1,251 existing holdings. Its largest new stake was Vanguard Total International Bond ETF: 174,739 shares worth $8.98M.

By sector, the portfolio is most concentrated in Energy at 9.9% of assets, up from 9.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was AstraZeneca, an estimated $38.6M trimmed.

  • Raymond James & Associates's largest Q2 2014 buy was Vanguard Total International Bond ETF: 174,739 shares worth $8.98M.
  • Raymond James & Associates added most to iShares MSCI EAFE ETF in Q2 2014, an estimated $38.2M increase.
  • Raymond James & Associates's biggest Q2 2014 reduction was AstraZeneca, cutting an estimated $38.6M.
  • Raymond James & Associates fully exited Weatherford International plc in Q2 2014, selling an estimated $20.6M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $16.2B portfolio in Q2 2014.
  • Raymond James & Associates opened 215 new positions and closed 120 in Q2 2014.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $16.2B.

Based on Raymond James & Associates's 13F filing for Q2 2014, filed 13 Aug 2014.